ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 73 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | -68.3% | 61,855 | -14.5% | 0.00% | – |
| Q4 2021 | $41,000 | -18.0% | 72,384 | +48.7% | 0.00% | – |
| Q3 2021 | $50,000 | -66.4% | 48,665 | -54.9% | 0.00% | – |
| Q2 2021 | $149,000 | -56.0% | 107,938 | -45.8% | 0.00% | – |
| Q1 2021 | $339,000 | +140.4% | 199,204 | +74.6% | 0.00% | – |
| Q4 2020 | $141,000 | -9.0% | 114,099 | +4.8% | 0.00% | – |
| Q3 2020 | $155,000 | +91.4% | 108,907 | +62.4% | 0.00% | – |
| Q2 2020 | $81,000 | -95.5% | 67,048 | -95.6% | 0.00% | -100.0% |
| Q1 2020 | $1,800,000 | +1039.2% | 1,524,933 | +1939.5% | 0.00% | – |
| Q4 2019 | $158,000 | -43.2% | 74,771 | -40.7% | 0.00% | – |
| Q3 2019 | $278,000 | +127.9% | 126,184 | +160.8% | 0.00% | – |
| Q2 2019 | $122,000 | -88.2% | 48,385 | -83.7% | 0.00% | – |
| Q1 2019 | $1,031,000 | +1008.6% | 296,267 | +636.8% | 0.00% | – |
| Q4 2018 | $93,000 | -52.6% | 40,209 | -21.0% | 0.00% | – |
| Q3 2018 | $196,000 | -49.6% | 50,879 | -55.8% | 0.00% | – |
| Q2 2018 | $389,000 | +1196.7% | 115,184 | +710.0% | 0.00% | – |
| Q1 2018 | $30,000 | 0.0% | 14,220 | -5.1% | 0.00% | – |
| Q4 2017 | $30,000 | -84.7% | 14,992 | -64.8% | 0.00% | – |
| Q3 2017 | $196,000 | -63.0% | 42,648 | -82.7% | 0.00% | – |
| Q2 2017 | $530,000 | +846.4% | 246,611 | +1041.3% | 0.00% | – |
| Q4 2016 | $56,000 | -54.5% | 21,608 | -31.5% | 0.00% | – |
| Q3 2016 | $123,000 | -32.0% | 31,561 | -46.4% | 0.00% | – |
| Q1 2016 | $181,000 | +174.2% | 58,873 | +244.7% | 0.00% | – |
| Q4 2015 | $66,000 | -68.1% | 17,081 | -74.8% | 0.00% | – |
| Q3 2015 | $207,000 | -51.1% | 67,706 | -32.2% | 0.00% | – |
| Q2 2015 | $423,000 | +340.6% | 99,866 | +301.2% | 0.00% | – |
| Q1 2015 | $96,000 | -27.3% | 24,893 | +26.7% | 0.00% | – |
| Q4 2014 | $132,000 | +28.2% | 19,654 | +96.3% | 0.00% | – |
| Q2 2014 | $103,000 | -34.4% | 10,010 | -28.0% | 0.00% | – |
| Q4 2013 | $157,000 | -40.3% | 13,902 | -43.0% | 0.00% | – |
| Q3 2013 | $263,000 | +69.7% | 24,377 | +46.1% | 0.00% | – |
| Q2 2013 | $155,000 | – | 16,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
| WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
| Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
| ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
| LMR Partners LLP | 148,309 | $319,000 | 0.02% |
| LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
| Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |